BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7914496)

  • 1. Fasciola hepatica: mebendazole and thiabendazole pharmacokinetics in sheep.
    Galtier P; Coulet M; Sutra JF; Biro-Sauveur B; Alvinerie M
    Exp Parasitol; 1994 Sep; 79(2):166-76. PubMed ID: 7914496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of early treatment with rafoxanide on antipyrine clearance in sheep infected with Fasciola hepatica.
    Benchaoui HA; McKellar QA
    Xenobiotica; 1993 Apr; 23(4):439-48. PubMed ID: 8101676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anthelmintic efficacy of mebendazole against adult Fasciola hepatica and a concurrent mixed nematode infection in sheep.
    Kelly JD; Chevis RA; Whitlock HV
    N Z Vet J; 1975 May; 23(5):81-4. PubMed ID: 1058369
    [No Abstract]   [Full Text] [Related]  

  • 4. Incidence of a subclinical fascioliasis on antipyrine clearance and metabolite excretion in sheep.
    Tufenkji AE; Alvinerie M; Pineau T; Boulard C; Galtier P
    Xenobiotica; 1988 Apr; 18(4):357-64. PubMed ID: 3400265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative incidence of experimental fascioliasis on corticosteroid pharmacokinetics in sheep.
    Alvinerie M; Tufenkji AE; Houin G; Toutain PL; Galtier P
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1989; 94(1):81-6. PubMed ID: 2576748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic subclinical ovine fascioliasis: plasma glutamate dehydrogenase, gamma-glutamyl transpeptidase and aspartate aminotransferase activities and their significance as diagnostic aids.
    Sykes AR; Coop RL; Robinson MG
    Res Vet Sci; 1980 Jan; 28(1):71-5. PubMed ID: 6103569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of ampicillin and pentobarbital in the course of subclinical fascioliasis in sheep.
    Tufenkji AE; Alvinerie M; Larrieu G; Houin G; Galtier P
    Res Vet Sci; 1991 Jan; 50(1):75-80. PubMed ID: 2047596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-course and accumulation of triclabendazole and its metabolites in bile, liver tissues and flukes collected from treated sheep.
    Moreno L; Ceballos L; Fairweather I; Lanusse C; Alvarez L
    Exp Parasitol; 2014 Jan; 136():14-9. PubMed ID: 24211244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the main route of drug entry in adult Fasciola hepatica: Further insights into closantel pharmacological activity.
    Ceballos L; Canton C; Cadenazzi G; Larsen K; Virkel G; Moreno L; Fairweather I; Lanusse C; Alvarez L
    Exp Parasitol; 2017 Oct; 181():23-29. PubMed ID: 28734749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decrease in albendazole sulphonation during experimental fascioliasis in sheep.
    Galtier P; Alvinerie M; Plusquellec Y; Tufenkji AE; Houin G
    Xenobiotica; 1991 Jul; 21(7):917-24. PubMed ID: 1776267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of sulphobromophthalein, lidocaine and indocyanine green in the course of subclinical fascioliasis in sheep.
    Tufenkji AE; Alvinerie M; Houin G; Galtier P
    Res Vet Sci; 1987 Nov; 43(3):327-30. PubMed ID: 3444979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host responses during experimental infection with Fasciola gigantica or Fasciola hepatica in Merino sheep I. Comparative immunological and plasma biochemical changes during early infection.
    Raadsma HW; Kingsford NM; Suharyanta ; Spithill TW; Piedrafita D
    Vet Parasitol; 2007 Feb; 143(3-4):275-86. PubMed ID: 17069976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and microsomal oxidation of praziquantel and its effects on the P450 system in three-month-old lambs infested by Fasciola hepatica.
    Giorgi M; Salvatori AP; Soldani G; Giusiani M; Longo V; Gervasi PG; Mengozzi G
    J Vet Pharmacol Ther; 2001 Aug; 24(4):251-9. PubMed ID: 11555180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ability of diamphenethide to control immature Fasciola hepatica in sheep at a lower than standard dose level.
    Rowlands DT; Clampitt RB; Macpherson IS
    Vet Rec; 1985 Feb; 116(7):182-4. PubMed ID: 2859685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic imaging in sheep hepatic fascioliasis: ultrasound, computer tomography and magnetic resonance findings.
    Gonzalo-Orden M; Millán L; Alvarez M; Sánchez-Campos S; Jiménez R; González-Gallego J; Tuñón MJ
    Parasitol Res; 2003 Aug; 90(5):359-64. PubMed ID: 12700980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of experimental fascioliasis on the activity of drug-metabolizing enzymes in lamb liver.
    Galtier P; Larrieu G; Tufenkji AE; Franc M
    Drug Metab Dispos; 1986; 14(1):137-41. PubMed ID: 2868858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ranide-MSD and ranizole-MSD in the treatment of fasciolasis and gastrointestinal nematode infections in sheep].
    Romaniuk K; Tarczyński S
    Wiad Parazytol; 1976; 22(2):177-84. PubMed ID: 1266266
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of hepatic and renal drug-metabolising enzyme activities in sheep given single or two-fold challenge infections with Fasciola hepatica.
    Calléja C; Bigot K; Eeckhoutte C; Sibille P; Boulard C; Galtier P
    Int J Parasitol; 2000 Jul; 30(8):953-8. PubMed ID: 10927086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated pharmacological assessment of flubendazole potential for use in sheep: disposition kinetics, liver metabolism and parasite diffusion ability.
    Moreno L; Alvarez L; Mottier L; Virkel G; Bruni SS; Lanusse C
    J Vet Pharmacol Ther; 2004 Oct; 27(5):299-308. PubMed ID: 15500567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An attempt to vaccinate sheep against Fasciola hepatica using a juvenile fluke antigen sheep antibody complex.
    Sandeman RM; Howell MJ; Campbell NJ
    Res Vet Sci; 1980 Sep; 29(2):255-9. PubMed ID: 6110229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.